NCT00836381 Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder Status COMPLETED Phase PHASE4
NCT00821184 Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder Status TERMINATED Phase PHASE3
NCT00795925 Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder Status COMPLETED Phase PHASE2
NCT00786448 Post Marketing Surveillance Study on Emselex After Launch in Germany Status COMPLETED Phase N/A
NCT00780832 Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder Status TERMINATED Phase NA
NCT00775281 Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. Status COMPLETED Phase N/A
NCT00773552 Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder Status WITHDRAWN Phase PHASE4
NCT00771394 Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia Status COMPLETED Phase PHASE4
NCT00771264 Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms Status COMPLETED Phase PHASE4
NCT00768521 A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107) Status COMPLETED Phase PHASE1
NCT00746681 Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder Status COMPLETED Phase PHASE2
NCT00730535 Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients Status COMPLETED Phase PHASE4
NCT00714792 Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections? Status COMPLETED Phase N/A
NCT00691093 Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy Status COMPLETED Phase N/A